Patent Assignment
Reel/Frame 057771/0587
Merger and Change of Name
Recorded: 2021-10-12
Pages: 5
Assignors
LUMENA PHARMACEUTICALS LLC
Executed: 2020-06-26
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2020-06-26
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 12, 2021
From: GEDULIN, BRONISLAVA; GREY, MICHAEL; O'DONNELL, NIALL
To: LUMENA PHARMACEUTICALS, INC.
Reel/Frame 057768/0021 →
Security Interest
Oct 12, 2021
From: MIRUM PHARMACEUTICALS, INC.
To: MULHOLLAND SA LLC
Reel/Frame 057771/0613 →
Change of Name
Oct 12, 2021
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 057787/0620 →
Change of Address
Oct 12, 2021
From: LUMENA PHARMACEUTICALS LLC
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 057788/0112 →
Release of Security Interest
Dec 4, 2025
From: MULHOLLAND SA LLC
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 073118/0670 →